flaura trial demonstrates efficacy in egfr-positive lung cancer
Published 4 years ago • 221 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:59
the flaura trial in egfr nsclc
-
0:57
examining the impact of the flaura trial in egfr-mutant nsclc
-
4:22
advanced-stage nsclc: overall survival data from flaura
-
0:58
adaura study demonstrates promising efficacy for osimertinib in egfr-mutant nsclc
-
2:09
dr. ramalingam on flaura trial results in egfr-mutant nsclc
-
5:42
osimertinib and the flaura trial
-
2:54
wclc 2023 highlights: flaura2 and egfr exon20-targeting tkis
-
0:48
investigating osimertinib for brain activity in egfr-mutated lung cancer
-
9:36
the flaura trial: practice-changing results for egfr mutation-positive nsclc (bmic-007)
-
7:00
flaura trial: impact of os data in advanced nsclc
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
5:18
frontline therapy for egfr plus nsclc: osimertinib’s impact
-
1:45
phase iii data support frontline osimertinib in egfr-mutant lung cancers
-
2:20
dr. peters on the flaura trial for egfr-mutated nsclc
-
30:32
2023 best of lung: targeted therapies in lung cancer
-
4:02
treatment of egfr mutated nsclc - 2022 program: targeted therapies forum - english
-
0:50
treating patients with egfr-mutant lung cancer with targeted therapies
-
2:09
dr. hassan on flaura trial results in egfr-mutant nsclc
-
58:24
time for even more precision in testing and treatment of egfr-mutated nsclc